UBS lowered the firm’s price target on Moderna (MRNA) to $108 from $140 and keeps a Buy rating on the shares following a model review.

AvidXchange (NASDAQ:AVDX – Free Report) had its target price cut by Wells Fargo & Company from $10.00 to $9.00 in a report issued on Monday, Benzinga reports. They currently have an equal weight ...

Failed to import article template. Reason: Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/chunks/Article.sznz2w9I.js ...

Q3 2024 Earnings Call Transcript October 23, 2024 Impinj, Inc. misses on earnings expectations. Reported EPS is $0.02136 EPS, ...

Sensex Today | Stock Market LIVE Updates | Equity markets fell for the third consecutive day on Wednesday, primarily driven ...

SBI Life reported a 39% YoY growth in consolidated net profit, reaching Rs 529 crore in Q2 FY25. Net premium income rose 1% ...

A small negative candle was formed on the daily chart at the new swing lows of 24,341 with minor upper and lower shadows.

Q2 2024 Earnings Conference Call October 23, 2024 9:00 PM ETCompany ParticipantsTeruaki Urago - General Manager, ...

Inflation, high interest rates and political instability made the wealthiest clients become more cautious with art purchases ...

UBS analyst Justin Forsythe maintained a Sell rating on Worldline (0QVI – Research Report) today and set a price target of €5.25. The ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxter’s chief financial officer, is ...

The fiery AGM came as large APA shareholder UniSuper sidestepped claims its $500 million sell-down in the stock was driven by ...